Iopofosine i-131 is under clinical development by Cellectar Biosciences and currently in Phase I for Ependymoma.

Potent Stream is a natural male health supplement designed to address prostate health by targeting the root cause that ...

Lenvatinib mesylate is under clinical development by Eisai and currently in Phase I for Epithelial Ovarian Cancer.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Dublin, Dec. 30, 2024 (GLOBE NEWSWIRE) -- The "Iodine Market by Source, Form, Application, and Region 2024-2032" report has ...